| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 02/28/2001 | EP1078925A1 4-Phenylpiperidine compounds |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1078818A2 Interior rearview mirror sound processing system |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077942A1 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 02/28/2001 | EP1077941A1 Compounds with growth hormone releasing properties |
| 02/28/2001 | EP1077940A1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077700A1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 02/28/2001 | EP1077695A2 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
| 02/28/2001 | EP0555483B1 Process for producing azacycloalkane derivative |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285348A Process for synthesizing propiverine hydrochloride |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | CA2111204C Piperidine derivatives having anxiolytic effect |
| 02/22/2001 | WO2001012750A1 Inhibition of polymerization of ethylenically unsaturated monomers |
| 02/22/2001 | WO2001012601A1 Novel anilide derivatives or salts thereof and drugs containing the same |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO2000032588A3 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | WO1999063992A8 Novel calcium channel drugs and uses |
| 02/22/2001 | DE19939756A1 New 1-(1-ethyl-piperidin-4-yl)-1-(phenyl or heterocyclyl)-alkanol derivatives, are 5-HT(2A) receptor antagonists useful e.g. for treating schizophrenia, depression, memory disorders or eating disorders |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/21/2001 | EP1077227A1 Stabilizer mixtures |
| 02/21/2001 | EP1077071A1 Labeled drugs and nitroxyl compounds to be used therein |
| 02/21/2001 | EP0983242A4 Method for producing particles of pyrithione salts |
| 02/21/2001 | CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/21/2001 | CN1284864A Novel formulation for use in pain management |
| 02/21/2001 | CN1062262C Substituted vinylurea derivatives and medicine containing the same |
| 02/20/2001 | US6191182 Subjecting p-halophenyl alkyl ketone to aminolysis with cyclic secondary amine to form cyclic amine-substituted phenyl alkyl ketone; halogination and reacting with amine compound; stevens rearrangement under basic condition |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191145 Anticoagulants; antiinflammatory agents |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/15/2001 | WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010839A2 Multivalent substituted ketoamides and amides for treating hair loss |
| 02/15/2001 | WO2001010838A1 Multivalent compounds |
| 02/15/2001 | WO2001010837A1 Multivalent sulfonamides |
| 02/15/2001 | WO2001010836A1 Method of treating hair loss using multivalent ketoamides and amides |
| 02/15/2001 | WO2001010835A1 Antibacterial agents |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2001010442A1 Retinal ganglion cell death inhibitors containing dihydropyridine compounds |
| 02/15/2001 | WO2001010429A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 02/15/2001 | WO2000047198A3 Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/14/2001 | EP1076055A1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 02/14/2001 | EP1076053A1 3-arylphenyl sulfide derivatives and insecticides and miticides |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP1075261A1 Mycobacterial inhibitors |
| 02/14/2001 | EP0842170B1 Diphenylmethylene piperidine derivatives |
| 02/14/2001 | CN1284065A Method for producing (-) Cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-piperidine |
| 02/14/2001 | CN1284059A Biphenylamidine derivatives |
| 02/14/2001 | CN1061977C Aryl substituted heterocycles |
| 02/13/2001 | US6187933 Bind to retinoid receptors; treating skin disorders |
| 02/13/2001 | US6187924 Inhibitors of matrix metalloproteinases and/or tumor necrosis factor-alpha-mediated diseases |
| 02/13/2001 | US6187792 Compounds with analgesic effect |
| 02/13/2001 | US6187791 Method of providing an antihistaminic effect in a hepatically impaired patient |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 02/08/2001 | WO2001009095A1 Mutilin derivatives and their use as antibacterials |
| 02/08/2001 | WO2001009094A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009093A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | WO2001008678A1 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies |
| 02/08/2001 | WO2001008672A2 Glucamine compounds for treating hepatitis virus infections |
| 02/08/2001 | DE19937494A1 New carboxylic acid amides are Factor Xa and serine protease inhibitors, useful for the treatment and prevention of thrombotic disorders, tumors and fibrin-dependent inflammation |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2380029A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | CA2362785A1 Glucamine compounds for treating hepatitis virus infections |
| 02/07/2001 | EP1074550A1 Process for the preparation of 3-substituted 4-phenyl-piperidine derivatives |
| 02/07/2001 | EP1074543A1 Aminopiperidine derivatives as integrin alpha v beta 3 antagonists |
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors |
| 02/07/2001 | CN1283197A Pleuromutilin derivatives as antimicrobials |
| 02/07/2001 | CN1283187A Novel dipydropyridine derivative |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1282730A Compounds with particular structure and anticancer activity and its preparing process |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184243 Neurological disorders |
| 02/06/2001 | US6184236 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative |
| 02/06/2001 | US6184234 Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines |
| 02/06/2001 | US6184233 Crystals having storage stability, oral absorption, solubility; hypotensive agents, platelet agglutination control agents |
| 02/06/2001 | US6184224 Drug resistance and side effect reduction |
| 02/06/2001 | CA2205574C Use of bleach activators for low perhydroxyl concentrations |
| 02/06/2001 | CA2141572C Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/02/2001 | CA2314750A1 Process for the preparation of 3-substituted 4-phenyl-piperidine derivatives |
| 02/01/2001 | WO2001007406A1 Novel amide derivatives |
| 02/01/2001 | WO2001007403A1 Naphthyl-substituted sulfonamides |
| 02/01/2001 | WO2001007402A1 Antiviral agents |